Abstract
An increasing percentage of drug development candidates suffer from poor aqueous solubility which in turn often times leads to poor oral absorption. This poses significant challenges in formulation development to ensure bioavailability following oral administration. Traditional approaches to increase dissolution of immediate release formulations include incorporation of surfactants, reduction of particle size and liquid vehicle formulations. More recently, size reduction of either the active pharmaceutical ingredient (API) particle or the drug delivery system down to the sub-micron range appears as a new promising approach to further increase dissolution rates of hydrophobic molecules. Nanonization of either the API, in the form of nanosuspensions typically stabilized with surfactants, or of the formulation vehicle such as with the use of self-nanoemulsified drug delivery systems and solid lipid nanoparticles has been successfully utilized to increase in vivo dissolution. Such nanotechnology has demonstrated significant impact on enhancing the bioavailability of drug candidates and addressing issues such as inadequate exposure or food effect. The goal of this review is to summarize recent advances in the utilization of nanosuspensions, solid lipid nanoparticles or nanoemulsions in drug delivery of immediate release dosage forms.
Keywords: Nanoparticles, Bioavailability, Nanosuspensions, Nanoemulsions, Dissolution, Formulation
Current Nanoscience
Title: Application of Nanoparticles in Oral Delivery of Immediate Release Formulations
Volume: 3 Issue: 2
Author(s): Filippos Kesisoglou, Santipharp Panmai and Yunhui Wu
Affiliation:
Keywords: Nanoparticles, Bioavailability, Nanosuspensions, Nanoemulsions, Dissolution, Formulation
Abstract: An increasing percentage of drug development candidates suffer from poor aqueous solubility which in turn often times leads to poor oral absorption. This poses significant challenges in formulation development to ensure bioavailability following oral administration. Traditional approaches to increase dissolution of immediate release formulations include incorporation of surfactants, reduction of particle size and liquid vehicle formulations. More recently, size reduction of either the active pharmaceutical ingredient (API) particle or the drug delivery system down to the sub-micron range appears as a new promising approach to further increase dissolution rates of hydrophobic molecules. Nanonization of either the API, in the form of nanosuspensions typically stabilized with surfactants, or of the formulation vehicle such as with the use of self-nanoemulsified drug delivery systems and solid lipid nanoparticles has been successfully utilized to increase in vivo dissolution. Such nanotechnology has demonstrated significant impact on enhancing the bioavailability of drug candidates and addressing issues such as inadequate exposure or food effect. The goal of this review is to summarize recent advances in the utilization of nanosuspensions, solid lipid nanoparticles or nanoemulsions in drug delivery of immediate release dosage forms.
Export Options
About this article
Cite this article as:
Kesisoglou Filippos, Panmai Santipharp and Wu Yunhui, Application of Nanoparticles in Oral Delivery of Immediate Release Formulations, Current Nanoscience 2007; 3 (2) . https://dx.doi.org/10.2174/157341307780619251
DOI https://dx.doi.org/10.2174/157341307780619251 |
Print ISSN 1573-4137 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6786 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A Review of IGF1 Signaling and IGF1-related Long Noncoding RNAs in Chemoresistance of Cancer
Current Cancer Drug Targets Food and Gastroesophageal Reflux Disease
Current Medicinal Chemistry Conjugates of Natural Compounds with Nitroxyl Radicals as a Basis for Creation of Pharmacological Agents of New Generation
Current Medicinal Chemistry In Situ Gels Based Drug Delivery Systems
Current Drug Therapy FXR, A Therapeutic Target for Bile Acid and Lipid Disorders
Mini-Reviews in Medicinal Chemistry Feud or Friend? The Role of the miR-17-92 Cluster in Tumorigenesis
Current Genomics Functional and Structural Characterization of Helicobacter pylori ClpX: A Molecular Chaperone of Hsp100 Family
Protein & Peptide Letters Anticancer Drug-Induced Immunomodulation and Cancer Therapeutics
Current Cancer Therapy Reviews The Effects of Montmorillonite and Bamboo Vinegar on Porcine Reproductive and Respiratory Syndrome Virus
Current Nanoscience Recent Trends in Fructooligosaccharides Production
Recent Patents on Food, Nutrition & Agriculture In vivo Piroxicam Metabolites: Possible Source for Synthesis of Central Nervous System (CNS) Acting Depressants
Central Nervous System Agents in Medicinal Chemistry Polyphenols: A Nutraceutical Approach Against Diseases
Recent Patents on Food, Nutrition & Agriculture The Secretin/Pituitary Adenylate Cyclase-Activating Polypeptide/ Vasoactive Intestinal Polypeptide Superfamily in the Central Nervous System
Central Nervous System Agents in Medicinal Chemistry Synthesis of 3-(2, 8, 9-trioxa-5-aza-1-germatricyclo [3.3.3.0] Undecane-1- yl)-3-(4-hydroxyl-3-methoxyphenyl)-propionic Acid and its Inhibitory Effect on the Cervical Tumor U14 in vitro and in vivo
Medicinal Chemistry Pharmacogenomics of Human Multidrug Resistance Associated Proteins
Current Pharmacogenomics and Personalized Medicine Microscopies at the Nanoscale for Nano-Scale Drug Delivery Systems
Current Drug Targets Xiaoyao Pill Improves the Affective Dysregulation of Sleep-deprived Female Mice by Inhibiting Brain Injury and Regulating the Content of Monoamine Neurotransmitter
Current Pharmaceutical Biotechnology Graphical Abstracts
Current Nanoscience Impaired Expression and Function of Signaling Pathway Enzymes by Anthocyanins: Role on Cancer Prevention and Progression
Current Enzyme Inhibition Biomarkers and Novel Therapeutic Targets in Gastrointestinal Stromal Tumors (GISTs)
Recent Patents on Anti-Cancer Drug Discovery